Endurant Capital Management LP - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2020$696,000
+71.4%
87,676
+57.4%
0.32%
+107.2%
Q1 2018$406,00055,7000.15%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q1 2018
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,625,000$12,269,0003.04%
GENDELL JEFFREY L 1,146,764$8,658,0001.11%
Broadfin Capital, LLC 1,029,012$7,769,0001.04%
RTW INVESTMENTS, LP 3,401,434$25,681,0000.97%
BRANDES INVESTMENT PARTNERS, LP 3,651,948$27,571,0000.66%
Aristides Capital LLC 71,520$540,0000.42%
Tekla Capital Management LLC 814,588$6,150,0000.23%
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV 36,100$273,0000.17%
Leap Investments LP 43,481$328,0000.15%
Brown Capital Management 1,829,886$13,816,0000.13%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders